Autoimmunity Immunological Tolerance

NewsGuard 100/100 Score

The term autoimmunity refers to a failure of the body’s immune system to recognize its own cells and tissues as “self.” Instead, immune responses are launched against these cells and tissues as if they were foreign or invading bodies.

Research conducted by Noel Rose and Witebsky in New York and Roitt and Doniach at University College London showed that diseases such as rheumatoid arthritis and thyrotoxicosis were linked to an inadequate immune tolerance and these conditions were caused by the body’s inability to fight “non-self” substances while also being able to ignore “self” substances.

This lack of immunological tolerance means the immune system mounts an attack against self determinants, through the production of antibodies. These reactive molecules are referred to as autoantibodies. How immunological tolerance develops is not yet understood, but three popular theories among immunologists are described below.

  • The “Clonal Deletion theory,” suggests that self-reactive lymphoid cells are eliminated during immunological development. Pioneers Frank Burnet and Pete MedMedawar were awarded the 1960 Nobel Prize in Physiology or Medicine for proposing their research into acquired immunological tolerance.
  • Proposed by Gustav Nossal, the “Clonal Anergy theory” suggests that reactive T- or B-cells become deactivated during development and fail to increase immune responses.
  • The “Idiotype Network theory,” first described by Jerne, held that certain antibody networks could neutralize autoantibodies.

Further theories currently being investigated include the “Clonal Ignorance theory,” and the “Suppressor population or Regulatory T cell theory.” The “Clonal Ignorance theory” suggests that self-reactive T cells not present in the thymus move to the periphery where they fail to encounter target antigens. Self-reactive B cells then fail to find the correct helper T-cell or antigen. The “Suppressor population or Regulatory T cell theory,” holds that regulatory T-lymphocytes such as CD4+FoxP3+ cells prevent, down regulate or reduce aggressive immune responses to self tissues.

Further Reading

Last Updated: Jul 13, 2023

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2023, July 13). Autoimmunity Immunological Tolerance. News-Medical. Retrieved on April 23, 2024 from https://www.news-medical.net/health/Autoimmunity-Immunological-Tolerance.aspx.

  • MLA

    Mandal, Ananya. "Autoimmunity Immunological Tolerance". News-Medical. 23 April 2024. <https://www.news-medical.net/health/Autoimmunity-Immunological-Tolerance.aspx>.

  • Chicago

    Mandal, Ananya. "Autoimmunity Immunological Tolerance". News-Medical. https://www.news-medical.net/health/Autoimmunity-Immunological-Tolerance.aspx. (accessed April 23, 2024).

  • Harvard

    Mandal, Ananya. 2023. Autoimmunity Immunological Tolerance. News-Medical, viewed 23 April 2024, https://www.news-medical.net/health/Autoimmunity-Immunological-Tolerance.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
COVID-19 doubles risk of early type 1 diabetes signs in high-risk children